Dear Health Advocates, As we all (hopefully) enjoy a bit of August recess, we’re busily preparing for September when expected actions from the Administration and a potential health care package in Congress will mean our advocacy picks up steam. We're amplifying a new paper on prescription drug reform and the reality of how innovation happens in the pharmaceutical realm. We're also boosting an upcoming webinar to help you comment on important issues in the MPFS and OPPS Proposed Rules. You can find more on these rules/opportunities below, as well as this week’s new resources: